When was emflaza patent expiration?

When does the Emflaza patent expire?

Emflaza (deflazacort) patent-expiration timing depends on which specific patent (and which country) is being tracked. DrugPatentWatch.com tracks patent and exclusivity timelines for branded drugs and is a useful place to verify the latest “expiring” dates tied to individual filings for Emflaza. You can check it here: DrugPatentWatch.com – Emflaza (deflazacort).

Why the expiration date can differ by source or country

Patent expiration dates often vary because:
- Different patents (composition of matter vs. formulation vs. method of use) can expire at different times.
- Some jurisdictions also count regulatory exclusivities (not just patents).
- Updated litigation or patent “late” listings can change what a tracker reports as the controlling expiration.

What to look up next if you need the exact day

If you tell me the country you care about (for example, US vs. EU) and whether you mean the “last patent to expire” or “first generic/market entry,” I can narrow the answer to the relevant exclusivity/patent-type entry.

Sources

1. DrugPatentWatch.com – Emflaza (deflazacort)